European Commission approves funding for Covid-19 vaccine

Monday 23 August 2021
Country

Denmark

The European Commission has approved funding from the Danish government to Bavarian Nordic A/S to support the company’s development of a vaccine for Covid-19. The funding will take the form of a repayable advance. The candidate vaccine, ABNCoV2, was developed by AdaptVac, a joint venture spun out of the University of Copenhagen, and licensed to Bavarian Nordic in July 2020. It uses AdaptVac’s viral capsid-like virus particle technology.